Showing results (181-190 of 190) with videos related to

Sort By:
Pageof 19
You have reached the last page of results.This site can display upto 190 results.
Nature Communications|October 28, 2015
Pharmaceutical screen identifies novel target processes for activation of autophagy with a broad translational potentialSantosh Chauhan, Zahra Ahmed, Steven B Bradfute, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|April 1, 2017
Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4Paul J Collins, Michelle L McCully, Laura Martínez-Muñoz, et al.
Journal of the American Academy of Dermatology|January 25, 2021
Comorbidity screening in hidradenitis suppurativa: Evidence-based recommendations from the US and Canadian Hidradenitis Suppurativa FoundationsAmit Garg, Neeta Malviya, Andrew Strunk, et al.
BMJ Open|December 23, 2022
Efficacy of guselkumab, a selective IL-23 inhibitor, in Preventing Arthritis in a Multicentre Psoriasis At-Risk cohort (PAMPA): protocol of a randomised, double-blind, placebo controlled multicentre trialRebecca H Haberman, Katrina A MacFarlane, Sydney Catron, et al.
Experimental Dermatology|November 29, 2018
Proceeding report of the Second Symposium on Hidradenitis Suppurativa Advances (SHSA) 2017Eran Shavit, Afsaneh Alavi, Falk G Bechara, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 16, 2023
Third and Fourth Vaccine Doses Broaden and Prolong Immunity to SARS-CoV-2 in Adult Patients with Immune-Mediated Inflammatory DiseasesMichelle W Cheung, Roya M Dayam, Janna R Shapiro, et al.
JAAD International|July 26, 2026
International expert consensus on transdermal drug delivery technologies in dermatologyJinjin Zhu, Yan Li, Xiuli Wang, et al.
Journal of the American Academy of Dermatology|December 26, 2024
North American clinical practice guidelines for the medical management of hidradenitis suppurativa in special patient populationsRaed Alhusayen, Serena Dienes, Megan Lam, et al.
JCI Insight|April 26, 2022
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune-mediated inflammatory diseasesRoya M Dayam, Jaclyn C Law, Rogier L Goetgebuer, et al.
JAMA Dermatology|November 26, 2025
Standardization of Lesion Classification and Assessment by Investigators in Clinical Trials for Hidradenitis Suppurativa: A Consensus Exercise Using a Modified Delphi ApproachAmit Garg, Andrew Strunk, Bria Midgette, et al.
Pageof 19